Challenge
The client was a clinical-stage biopharma company with multiple gene therapy platforms targeting rare diseases. A need was identified to define and early commercialization strategy and explore business model options to support long-term market entry planning.
Approach
We conducted a situational analysis to outline the external and internal landscape in markets of interest. Outputs were leveraged to conduct a workshop to define the critical success factors, commercial objectives, and strategic plan. We integrated the outputs to support market entry model option assessment, considering the client's corporate strategy and forecasting models. Defined recommended model and associated FTE and cost needs.
Impact
All material and recommendations were packaged into a Board of Directors deck to support near-term planning leading up to target launch dates.
